These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6137372)

  • 1. Renal effects of beta blockade in essential hypertension.
    de Leeuw PW; Birkenhäger WH
    Eur Heart J; 1983 Jul; 4 Suppl D():13-7. PubMed ID: 6137372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal response to propranolol treatment in hypertensive humans.
    de Leeuw PW; Birkenhäger WH
    Hypertension; 1982; 4(1):125-31. PubMed ID: 6120895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of arotinolol on hemodynamics and adrenergically induced renin release and renal vasoconstriction.
    Suzuki-Kusaba M; Hisa H; Kimura T; Satoh S
    Arzneimittelforschung; 1988 May; 38(5):671-7. PubMed ID: 2458109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary kallikrein activity, renal hemodynamics, and electrolyte handling during chronic beta blockade with propranolol in hypertension.
    O'Connor DT; Preston RA
    Hypertension; 1982; 4(5):742-9. PubMed ID: 6125474
    [No Abstract]   [Full Text] [Related]  

  • 5. The renal circulation in essential hypertension.
    de Leeuw PW; Birkenhäger WH
    J Hypertens; 1983 Dec; 1(4):321-31. PubMed ID: 6398328
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemodynamic and adrenergic responses of bevantolol and propranolol in hypertensives.
    Snedden W; Fernandez PG; Vasdev S; Bolli P
    Can J Cardiol; 1989; 5(1):37-41. PubMed ID: 2563955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efferent renal nerve activity in hypertensive man.
    de Leeuw PW; Birkenhäger WH
    Clin Exp Hypertens A; 1987; 9 Suppl 1():281-92. PubMed ID: 2890453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal sequelae of sympathetic hyperactivity].
    Watschinger B; Habicht A
    Wien Med Wochenschr; 2004; 154 Spec No 1(1):7-9. PubMed ID: 15346546
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurohormonal influences on maintenance and reversal of two-kidney one-clip renal hypertension.
    Nyström HC; Jia J; Johansson M; Lambert G; Bergström G
    Acta Physiol Scand; 2002 Jul; 175(3):245-51. PubMed ID: 12100364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenergic blockade alone does not decrease renal perfusion in black hypertensives.
    Brater DC; Anderson S; Kaplan NM; Ram CV
    J Hypertens; 1984 Feb; 2(1):43-8. PubMed ID: 6152277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic overactivity and arterial hypertension in renal failure.
    Orth SR; Amann K; Strojek K; Ritz E
    Nephrol Dial Transplant; 2001; 16 Suppl 1():67-9. PubMed ID: 11369825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some aspects of kidney function, the renin-aldosterone system and sympathetic activity in essential hypertension.
    Pedersen EB
    Acta Med Scand Suppl; 1980; 636():1-66. PubMed ID: 6103641
    [No Abstract]   [Full Text] [Related]  

  • 16. Adrenergic vasoconstriction as a cause of inadequate hypotensive response to beta-adrenergic blockade.
    Birkenhäger WH; DeLeeuw PW
    Hypertension; 1983; 5(5 Pt 2):III31-5. PubMed ID: 6138310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-adrenergic blockade in some cardiovascular diseases.
    Tarazi RC
    Cardiovasc Clin; 1975; 7(1):173-85. PubMed ID: 238741
    [No Abstract]   [Full Text] [Related]  

  • 18. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
    Pernow J; Lundberg JM
    Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathetic vasoconstriction and renin secretion cause pressor responses to thyrotropin-releasing hormone in rats.
    Mattila J; Buñag RD
    J Pharmacol Exp Ther; 1986 Jul; 238(1):232-6. PubMed ID: 3088259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol and beta-adrenergic receptor blocking drugs in the treatment of hypertension.
    Prichard BN
    Br J Clin Pharmacol; 1982 Jan; 13(1):51-60. PubMed ID: 6121573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.